Oligonucleotide-based knockdown technologies: Antisense versus RNA interference

被引:55
作者
Achenbach, TV [1 ]
Brunner, B [1 ]
Heermeier, K [1 ]
机构
[1] Aventis Pharma Deutschland GmbH, DI&A LG Funct Genom, D-65926 Frankfurt, Germany
关键词
antisense agents; gene expression; interference; knockdown; RNA;
D O I
10.1002/cbic.200300708
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The postgenomic era is characterized by an almost intimidating amount of information regarding the sequences and expression of previously unknown genes. In response, researchers have developed an increasing interest in functional studies. At the start of such a study, one may have little more than sequence information and bioinformatic annotation. The next step is to hypothesize a potential role in the contest of a cell. Testing of the hypothesis needs to be fast, cheap, and applicable to a large number of genes. Knockdown methods that rely on binding of antisense oligonucleotides to mRNA combined with a subsequent functional assay in cell culture fulfill these requirements: sequence information is sufficient for synthesis of active inhibitors. Depending on the in vitro model chosen, knockdown of gene expression can be achieved with medium or even high throughput. The two most popular methods of knockdown in cell culture are the use of antisense oligonucleotides that rely on ribonuclease H (RNAse H)-dependent cleavage of mRNA, and RNA interference triggered by small double-stranded RNA molecules. Both methods act in a sequence-specific manner and can give efficient knockdown. IN both cases, researchers struggle with nonspecific "off-target" effects and the difficulty of site selection. Studies that compare the methods differ in their judgment as to which method is superior.
引用
收藏
页码:928 / 935
页数:8
相关论文
共 48 条
[1]   Bcl-2 independence of flavopiridol-induced apoptosis -: Mitochondrial, depolarization in the absence of cytochrome c release [J].
Achenbach, TV ;
Müller, R ;
Slater, EP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (41) :32089-32097
[2]   Importance of nucleotide sequence and chemical modifications of antisense oligonucleotides [J].
Agrawal, S .
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 1999, 1489 (01) :53-68
[3]   Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3 [J].
Alexopoulou, L ;
Holt, AC ;
Medzhitov, R ;
Flavell, RA .
NATURE, 2001, 413 (6857) :732-738
[4]   RNA interference may be more potent than antisense RNA in human cancer cell lines [J].
Aoki, Y ;
Cioca, DP ;
Oidaira, H ;
Kamiya, J ;
Kiyosawa, K .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2003, 30 (1-2) :96-102
[5]   Novel mechanisms for antisense-mediated regulation of gene expression [J].
Baker, BF ;
Monia, BP .
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 1999, 1489 (01) :3-18
[6]   CHROMOPHORE-ASSISTED LASER INACTIVATION OF CELLULAR PROTEINS [J].
BEERMANN, AEL ;
JAY, DG .
METHODS IN CELL BIOLOGY, VOL 44, 1994, 44 :715-732
[7]   Mac-1 (CDllb/CD18) is an oligodeoxynucleotide-binding protein [J].
Benimetskaya, L ;
Loike, JD ;
Khaled, Z ;
Loike, G ;
Silverstein, SC ;
Cao, L ;
Khoury, JE ;
Cai, TQ ;
Stein, CA .
NATURE MEDICINE, 1997, 3 (04) :414-420
[8]   Role for a bidentate ribonuclease in the initiation step of RNA interference [J].
Bernstein, E ;
Caudy, AA ;
Hammond, SM ;
Hannon, GJ .
NATURE, 2001, 409 (6818) :363-366
[9]   The efficacy of small interfering RNAs targeted to the type 1 insulin-like growth factor receptor (IGF1R) is influenced by secondary structure in the IGF1R transcript [J].
Bohula, EA ;
Salisbury, AJ ;
Sohail, M ;
Playford, MP ;
Riedemann, J ;
Southern, EM ;
Macaulay, VM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (18) :15991-15997
[10]   Specific inhibition of PTEN expression reverses hyperglycemia in diabetic mice [J].
Butler, M ;
McKay, RA ;
Popoff, IJ ;
Gaarde, WA ;
Witchell, D ;
Murray, SF ;
Dean, NM ;
Bhanot, S ;
Monia, BP .
DIABETES, 2002, 51 (04) :1028-1034